Medlinker Executive Li Yue Unveils Patient-Centric Full-Process Management Model

Recently, the “First ‘Patient Insights, Education, and Management’ Forum,” hosted by Liu Qian Marketing Studio, was held in Shanghai. Representatives from well-known enterprises such as Pfizer, Roche, Tencent Healthcare, Sina Healthcare, DXY, Zentiva, Kantar Health, and Haodafu attended the event. Among them, Li Yue, Vice President of Medlinker, attended the forum and delivered a keynote speech.

Li Yue, Vice President of Yilian (Photo provided by the company)

Li Yue previously served as Vice President of Merck & Co. (China) and General Manager of the North China Branch. With over 20 years of experience in the pharmaceutical industry, she possesses a thorough understanding and profound insights into the sector. Since joining Medlinker in January this year, she has been responsible for business operations including collaborations between the company and pharmaceutical and medical device enterprises.

At the conference, Li Yue delivered a presentation titled “How to Build an Online-Plus-Offline Full-Cycle Patient Management System,” sharing Medlinker’s patient-centric full-cycle management model in light of the new developments in the pharmaceutical industry in recent years.

For many years, due to various factors such as the uneven distribution of medical resources and inadequate regulatory mechanisms, China’s pharmaceutical and healthcare industry has operated in a “physician-centric” manner, resulting in relatively strained doctor-patient relationships. Against this backdrop, the state has continuously deepened healthcare reforms. Measures such as the separation of prescribing from dispensing, the “Two-Invoice System,” tiered diagnosis and treatment, and the liberalization of physicians’ multi-site practice represent various attempts to break the outdated model of “sustaining healthcare through drug sales” and optimize the allocation of medical resources. They also constitute active institutional efforts to enhance patient satisfaction.

Li Yue believes that being “patient-centered” begins with exploring patient needs. Needs vary by disease, and the assistance required differs depending on the treatment. Only by genuinely understanding patients’ psychology, behaviors, and expectations can effective methods for patient education, communication, and management be identified.

In recent years, the rise of internet healthcare has been transforming medical service models in unprecedented ways, supporting national healthcare reform and accelerating the industry’s shift toward patient-centered care.

In the realm of single-disease management, Medlinker has already explored a holistic, patient-centered healthcare solution for hepatitis C patients through its strategic partnership with Gilead. Recognizing that diagnosis often involves a prolonged process, Medlinker provides continuous care services throughout the journey; regular monitoring services are employed to verify treatment efficacy; and patient assistance programs along with patient clubs help address issues related to medication accessibility. Two hepatology experts on the platform—Director Zhang Liu from Guiyang Fifth People’s Hospital and Director Yue Wei from Yunnan Provincial First People’s Hospital—have highly affirmed Medlinker’s effectiveness in resolving the “difficulty in accessing medical care” for patients in remote areas.

MedLink’s one-stop patient management service addresses issues ranging from diagnosis to payment, offering personalized financial support through the Yilian Patient Club. It also provides patients with comprehensive assistance programs, patient care initiatives, and end-to-end DTP (Direct-to-Patient) services. By establishing a closed-loop service model that includes remote follow-up consultations, electronic prescriptions, and home delivery of medications, it resolves multiple pain points in the diagnosis and treatment process while fostering effective patient interaction and feedback.

Li Yue stated that the one-stop patient management service demonstrates Yilian’s robust capability to integrate the healthcare industry chain. By leveraging technological capabilities such as medical big data, AI-assisted diagnosis and treatment, and distribution services, and centering on its real-name physician platform, Yilian connects partners including pharmaceutical and medical device manufacturers and commercial insurance providers. This approach comprehensively integrates the supply side of the healthcare industry, providing hospitals with standardized and customized medical solutions, and ultimately delivering efficient, high-quality, and considerate services to patients. In doing so, it not only enhances hospital efficiency but also empowers patients, establishing a truly patient-centric new system.